Geldanamycin inhibits proliferation and motility of human HER2/neu-overexpressing breast cancer cell line SKBr3 / 南方医科大学学报
Journal of Southern Medical University
; (12): 1480-1484, 2007.
Article
em Zh
| WPRIM
| ID: wpr-283104
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the antitumor effect of a benzoquinone ansamycin antibiotic, geldanamycin (GA), against HER2 /neu tyrosine kinase-overexpressing human breast cancer cell line SKBr3.</p><p><b>METHODS</b>To evaluate the antitumor activity of GA, the degradation of HER2 /neu tyrosine kinase in GA-treated SKBr3 cells was analyzed by Western blotting, their proliferation assessed using MTT assay, and the cell cycle distribution identified by flow cytometry. RT-PCR and Real-time PCR were employed to detect cyclin D1 mRNA expression and cell culture inserts model was used to evaluate the motility of the cells.</p><p><b>RESULTS</b>GA induced a dose- and time-dependent degradation of HER2 /neu tyrosine kinase and cell proliferation inhibition. GA treatment obviously decreased the survival rates of the cancer cells, leading also to a dose-dependent G(1) arrest. The antitumor effects of GA proved to be relevant with declined transcription of cyclin D1. The GA-treated cells also exhibited reduced motility.</p><p><b>CONCLUSION</b>GA can efficiently destabilize HER2 /neu tyrosine kinase and inhibit the proliferation and motility of human breast cancer cell line SKBr3 overexpressing HER2 /neu tyrosine kinase.</p>
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Farmacologia
/
Neoplasias da Mama
/
Regulação para Baixo
/
Expressão Gênica
/
Movimento Celular
/
Benzoquinonas
/
Receptor ErbB-2
/
Linhagem Celular Tumoral
/
Lactamas Macrocíclicas
/
Proliferação de Células
Limite:
Female
/
Humans
Idioma:
Zh
Revista:
Journal of Southern Medical University
Ano de publicação:
2007
Tipo de documento:
Article